CAT No: CP09706
CAS No:111524-95-9
Synonyms/Alias:Fmoc-D-Phg-OH;111524-95-9;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylaceticacid;Fmoc-D-Phenylglycine;Fmoc-D-alpha-phenylglycine;Fmoc-L-|A-Phenylglycine;ST51037462;(R)-[(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)]-PHENYL-ACETICACID;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-phenyl-aceticacid;(2R)-([(9H-FLUOREN-9-YL-METHOXY)CARBONYL]AMINO)(PHENYL)ACETICACID;(2R)-{[(9H-Fluoren-9-Yl-Methoxy)Carbonyl]Amino}(Phenyl)AceticAcid;AC1MBSTC;FMOC-D-A-PHENYLGLYCINE;SCHEMBL118281;AC1Q71D5;00211_FLUKA;(R)-N-FMOC-PHENYLGLYCINE;FMOC-D-PHENYLGLYCINEAMIDE;MolPort-003-725-671;PCJHOCNJLMFYCV-OAQYLSRUSA-N;ZINC4521085;N-ALPHA-FMOC-D-PHENYLGLYCINE;ANW-75220;CF-295;MFCD00190891
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.